
-
Architects: JUNGLIM Architecture
- Area: 22692 m²
-
Photographs:Namgoong Sun
Text description provided by the architects. Dong Hwa Pharmaceuticals R&D center currently made aims to move the deteriorated R&D center, located inside the Anyang plant of Dong Hwa Pharm. Co., Ltd. in Gyeonggi-do. As the planned site for the movement is decided as Giheung Venture Valley in Yongin, the R&D center expects that it will have a space that can take role as the brain of the company under further developed conditions while maintaining the existing research process. As for programs, all existing 6 departments including new drug, natural materials, pharmacology, medicine method, biology, and analysis moved, and the building for pilot tests and animal tests which enable internal test production has been expanded. The R&D center considers the layout of actually being used as equipment in accordance with the user process, designed to conform to BSL standards, under preparation for approval in the future.














